Usefulness of serum M30 and M65 levels to predict response to neoadjuvant chemotherapy in patients with breast cancer.

H Mehmet Turk,Altay Aliyev, Rabia Sevda Celik,Mesut Seker,Ezgi Coban,Tarık Demir,Tuba Baydas,Abdurrahim Kocyigit

Current Problems in Cancer（2020）

引用 1|浏览17

暂无评分

摘要

M30 and M65 levels are not of predictive values of response to breast cancer patients receiving neoadjuvant chemotherapy. Nevertheless, M30 and M65 levels increased when patients kept receiving anthracycline containing chemotherapy.

查看译文

关键词

Breast cancer,M30,M65,Neoadjuvant chemotherapy

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要